| SEGMENT INFORMATION |
NOTE
18 – SEGMENT INFORMATION
For the three and
six months ended June 30, 2018, the Company operated in three reportable business segments - (1) the real property operating segment,
(2) the medical related consulting services segment, and (3) the performing development services for hospitals and other customers
and sales of developed products to hospitals and other customers segment. For the three
and six months ended June 30, 2017, the Company operated in two reportable business segments - (1) the real property operating
segment, and (2) the medical related consulting services segment. The Company’s reportable segments are strategic
business units that offer different services and products. They are managed separately based on the fundamental differences in
their operations. Information with respect to these reportable business segments for the three and six months ended June 30, 2018
and 2017 was as follows:
| |
|
Three Months |
|
|
Three Months |
|
|
Six Months |
|
|
Six Months |
|
| |
|
Ended |
|
|
Ended |
|
|
Ended |
|
|
Ended |
|
| |
|
June 30, 2018 |
|
|
June 30, 2017 |
|
|
June 30, 2018 |
|
|
June 30, 2017 |
|
| Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
$ |
278,872 |
|
|
$ |
222,254 |
|
|
$ |
575,495 |
|
|
$ |
222,254 |
|
| Medical related consulting services – related parties |
|
|
141,996 |
|
|
|
152,497 |
|
|
|
141,996 |
|
|
|
218,783 |
|
| Development services and sales of developed products |
|
|
75,225 |
|
|
|
— |
|
|
|
86,515 |
|
|
|
— |
|
| |
|
|
496,093 |
|
|
|
374,751 |
|
|
|
804,006 |
|
|
|
441,037 |
|
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
32,625 |
|
|
|
32,943 |
|
|
|
65,249 |
|
|
|
32,943 |
|
| Medical related consulting services |
|
|
3,991 |
|
|
|
1,187 |
|
|
|
7,997 |
|
|
|
1,213 |
|
| Development services and sales of developed products |
|
|
87,980 |
|
|
|
— |
|
|
|
174,729 |
|
|
|
— |
|
| |
|
|
124,596 |
|
|
|
34,130 |
|
|
|
247,975 |
|
|
|
34,156 |
|
| Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
24,932 |
|
|
|
42,000 |
|
|
|
261,918 |
|
|
|
42,000 |
|
| Medical related consulting services |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Development services and sales of developed products |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| |
|
|
24,932 |
|
|
|
42,000 |
|
|
|
261,918 |
|
|
|
42,000 |
|
| Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
5,617 |
|
|
|
(1,234 |
) |
|
|
(232,083 |
) |
|
|
(1,234 |
) |
| Medical related consulting services |
|
|
16,456 |
|
|
|
54,782 |
|
|
|
(157,018 |
) |
|
|
(161,789 |
) |
| Development services and sales of developed products |
|
|
(196,896 |
) |
|
|
— |
|
|
|
(297,028 |
) |
|
|
— |
|
| Other (a) |
|
|
(1,168,992 |
) |
|
|
(484,056 |
) |
|
|
(2,208,655 |
) |
|
|
(816,818 |
) |
| |
|
$ |
(1,343,815 |
) |
|
$ |
(430,508 |
) |
|
$ |
(2,894,784 |
) |
|
$ |
(979,841 |
) |
| Identifiable long-lived tangible assets at June 30, 2018 and December 31, 2017 |
|
June 30, 2018 |
|
|
December 31, 2017 |
|
| Real property operating |
|
$ |
7,745,277 |
|
|
$ |
7,645,371 |
|
| Medical related consulting services |
|
|
12,507 |
|
|
|
20,558 |
|
| Development services and sales of developed products |
|
|
110,743 |
|
|
|
5,857 |
|
| |
|
$ |
7,868,527 |
|
|
$ |
7,671,786 |
|
| Identifiable long-lived tangible assets at June 30, 2018 and December 31, 2017 |
|
June 30, 2018 |
|
|
December 31, 2017 |
|
| United States |
|
$ |
7,746,017 |
|
|
$ |
7,646,270 |
|
| China |
|
|
122,510 |
|
|
|
25,516 |
|
| |
|
$ |
7,868,527 |
|
|
$ |
7,671,786 |
|
| |
(a) |
The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level. |
|